You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
EFFICIENT AND EFFECTIVE MOBILE DATA CAPTURE IN AN ACRIN CLIN TRIAL ENVIRON
SBC: ADVANCED DIGITAL SYSTEMS, INC. Topic: N/AN/A
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Nanodroplet PCR Lab-Chip for Clinical Pathogen Detection
SBC: ADVANCED LIQUID LOGIC Topic: N/ADESCRIPTION (provided by applicant): Rapid and accurate detection and identification of pathogens is crucial for the effective management and treatment of infectious disease. While molecular diagnostic techniques including PCR are a promising approach for rapid and sensitive detection of pathogens, they suffer from a number of technical drawbacks which have slowed their acceptance in the clinic. ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Discovery of Peptide-based Bone Morphogenic Protein Mimetics
SBC: AFFINERGY, LLC Topic: N/ADESCRIPTION (provided by applicant): In this proposal, we present a novel approach for the identification and immobilization of a BMP mimetic. We plan to use phage display technology to identify peptides that mimic BMP-like signaling of the BMP receptors. These peptides will be linked to a previously identified high-affinity, collagen-binding peptide. The resulting hybrid molecule will allow contr ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Improved Orthopedic Implant Surface Coatings
SBC: AFFINERGY, LLC Topic: N/AEndosseous metallic implants are common alloplastic devices used in medicine and dentistry. The orthopedic and dental marketplace continues to grow and indications for implants are expanding. There is a perceived need to improve both the successful healing (osseointegration) and the long term outcome of implants by control of interfacial reactivity during healing and remodeling. The growth of know ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Electrochemical RT activity assay for measuring HIV load
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): In this Phase I SBIR project Alderon Biosciences Inc. (ABI) proposes to demonstrate the feasibility of using electrochemical reverse transcriptase (eRT) assays for determinations of HIV viral load in clinical samples. Success will set the stage for Phase II development, FDA approval, and production of commercial kits using this advanced technology. The long-r ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Electrochemical Quantification of HCV RNA
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): The National Institutes of Allergy and Infectious Disease have called for better tools for the detection and diagnosis of emerging and re-emerging infectious diseases. To meet this need, Alderon Biosciences Inc. (ABI) proposes to develop innovative, low-cost tests with sensitivity adequate for determining HCV viral load. Reliable and affordable HCV viral load t ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Analysis Tools for Detection and Diagnosis of Biological Threats
SBC: ALPHA-GAMMA TECHNOLOGIES, INC. Topic: CBD04113DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...
SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense -
Transdermal Hydromorphone for Acute and Chronic Pain
SBC: Altea Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently undergoing Phase 1 clinical trials for basal insulin delivery, revolutionizes the way in which medicine ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Non-Invasive Drug Delivery by Thermal Microporation
SBC: Altea Therapeutics Corporation Topic: N/ADESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) transdermal drug delivery system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently undergoing Phase 1 clinical trials for transdermal delivery of insulin and ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Diagnostic for Age-Related Macular Degeneration
SBC: APELIOTUS TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): Apeliotus Technologies proposes to develop a commercial diagnostic for the early detection of age-related macular degeneration (ARMD). It relies on a functional test of dark adaptation kinetics (the transition from being light-adapted to being dark-adapted) that has been shown in previous work to detect the onset of ARMD at least four years before it is clinic ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health